Provention Bio Top Management
Provention Bio employs about 174 people. The company is managed by 9 executives with a total tenure of roughly 406 years, averaging almost 45.0 years of service per executive, having 19.33 employees per reported executive. Analysis of Provention Bio's management performance can provide insight into the company performance.
Provention |
Provention Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.4301) % which means that it has lost $0.4301 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9766) %, meaning that it created substantial loss on money invested by shareholders. Provention Bio's management efficiency ratios could be used to measure how well Provention Bio manages its routine affairs as well as how well it operates its assets and liabilities.Provention Bio Workforce Comparison
Provention Bio is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,432. Provention Bio holds roughly 174 in number of employees claiming about 7% of equities under Health Care industry.
Provention Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Provention Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Provention Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Provention Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sessa Capital Master Lp over a year ago Disposition pursuant to a tender of shares in a change of control transaction by Sessa Capital Master Lp of Provention Bio | ||
Sessa Capital Master Lp over a year ago Provention Bio exotic insider transaction detected | ||
Sessa Capital Master Lp over a year ago Exercise of in-the-money or at-the-money derivative position by Sessa Capital Master Lp of 8879023 shares of Provention Bio | ||
Francisco Leon over a year ago Bona fide gift to Francisco Leon of 1500000 shares of Provention Bio subject to Section 16 |
Provention Bio Notable Stakeholders
A Provention Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Provention Bio often face trade-offs trying to please all of them. Provention Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Provention Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jason Levine | VP Marketing | Profile | |
| Sarah OBrien | Chief Officer | Profile | |
| Kaelan Hollon | VP Communications | Profile | |
| Robert Doody | VP Relations | Profile | |
| Eleanor MD | Chief Officer | Profile | |
| Francisco MD | CoFounder Officer | Profile | |
| Thierry Chauche | Chief Officer | Profile | |
| LLM JD | Chief Officer | Profile | |
| Christina Yi | Chief Officer | Profile |
Provention Bio Workforce Analysis
Traditionally, organizations such as Provention Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Provention Bio within its industry.Provention Bio Manpower Efficiency
Return on Provention Bio Manpower
| Revenue Per Employee | 74.1K | |
| Revenue Per Executive | 1.4M | |
| Net Loss Per Employee | 652.7K | |
| Net Loss Per Executive | 12.6M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Provention Stock
If you are still planning to invest in Provention Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provention Bio's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |